Marko Bagaric active positions
| Companies | Position | Start | End |
|---|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Chief Executive Officer | - | - |
Berlin Heals Holding AG
 Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Director/Board Member | 2013-12-31 | - |
| Chief Executive Officer | 2013-12-31 | - | |
| Founder | 2013-12-31 | - |
Career history of Marko Bagaric
Former positions of Marko Bagaric
| Companies | Position | Start | End |
|---|---|---|---|
| Swiss Invest Partners AG | Portfolio Manager-Equities | 2009-10-05 | - |
Statistics
International
| Switzerland | 4 |
| Germany | 2 |
Operational
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Portfolio Manager-Equities | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
| Swiss Invest Partners AG | Finance |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Health Technology |
Berlin Heals Holding AG
Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Health Technology |
- Stock Market
- Insiders
- Marko Bagaric
- Experience
